Annual EBIT
-$14.42 M
-$800.70 K-5.88%
December 1, 2023
Summary
- As of February 12, 2025, ZVSA annual earnings before interest & taxes is -$14.42 million, with the most recent change of -$800.70 thousand (-5.88%) on December 1, 2023.
- During the last 3 years, ZVSA annual EBIT has fallen by -$2.25 million (-18.53%).
- ZVSA annual EBIT is now -98.56% below its all-time high of -$7.26 million, reached on December 31, 2021.
Performance
ZVSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.27 M
+$484.40 K+17.59%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA quarterly earnings before interest & taxes is -$2.27 million, with the most recent change of +$484.40 thousand (+17.59%) on September 1, 2024.
- Over the past year, ZVSA quarterly EBIT has increased by +$557.00 thousand (+19.71%).
- ZVSA quarterly EBIT is now -37.19% below its all-time high of -$1.65 million, reached on September 1, 2021.
Performance
ZVSA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$9.63 M
+$633.10 K+6.17%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA TTM earnings before interest & taxes is -$9.63 million, with the most recent change of +$633.10 thousand (+6.17%) on September 1, 2024.
- Over the past year, ZVSA TTM EBIT has increased by +$3.03 million (+23.93%).
- ZVSA TTM EBIT is now -481.87% below its all-time high of -$1.65 million, reached on September 1, 2021.
Performance
ZVSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ZVSA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | +19.7% | +23.9% |
| 3 y3 years | -18.5% | -20.5% | -8.4% |
| 5 y5 years | -18.5% | -20.5% | -8.4% |
ZVSA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.6% | at low | -28.6% | +55.9% | -181.6% | +46.3% |
| 5 y | 5-year | -98.6% | at low | -37.2% | +55.9% | -481.9% | +46.3% |
| alltime | all time | -98.6% | at low | -37.2% | +55.9% | -481.9% | +46.3% |
ZyVersa Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.27 M(-17.6%) | -$9.63 M(-6.2%) |
| Jun 2024 | - | -$2.75 M(-2.6%) | -$10.26 M(-18.9%) |
| Mar 2024 | - | -$2.83 M(+59.1%) | -$12.66 M(-12.2%) |
| Dec 2023 | -$14.42 M(+5.9%) | -$1.78 M(-38.8%) | -$14.42 M(-16.1%) |
| Sep 2023 | - | -$2.90 M(-43.6%) | -$17.20 M(-4.0%) |
| Jun 2023 | - | -$5.15 M(+12.1%) | -$17.92 M(+22.3%) |
| Mar 2023 | - | -$4.59 M(+0.9%) | -$14.65 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$13.62 M(+87.5%) | -$4.55 M(+25.6%) | -$13.64 M(+25.7%) |
| Sep 2022 | - | -$3.62 M(+92.4%) | -$10.85 M(+22.2%) |
| Jun 2022 | - | -$1.88 M(-47.4%) | -$8.88 M(+26.9%) |
| Mar 2022 | - | -$3.58 M(+102.9%) | -$7.00 M(+104.7%) |
| Dec 2021 | -$7.26 M(-40.3%) | - | - |
| Dec 2021 | - | -$1.76 M(+6.6%) | -$3.42 M(+106.6%) |
| Sep 2021 | - | -$1.65 M | -$1.65 M |
| Dec 2020 | -$12.17 M | - | - |
FAQ
- What is ZyVersa Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual EBIT year-on-year change?
- What is ZyVersa Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly EBIT year-on-year change?
- What is ZyVersa Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics TTM EBIT year-on-year change?
What is ZyVersa Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ZVSA is -$14.42 M
What is the all time high annual EBIT for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual earnings before interest & taxes is -$7.26 M
What is ZyVersa Therapeutics annual EBIT year-on-year change?
Over the past year, ZVSA annual earnings before interest & taxes has changed by -$800.70 K (-5.88%)
What is ZyVersa Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ZVSA is -$2.27 M
What is the all time high quarterly EBIT for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly earnings before interest & taxes is -$1.65 M
What is ZyVersa Therapeutics quarterly EBIT year-on-year change?
Over the past year, ZVSA quarterly earnings before interest & taxes has changed by +$557.00 K (+19.71%)
What is ZyVersa Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ZVSA is -$9.63 M
What is the all time high TTM EBIT for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high TTM earnings before interest & taxes is -$1.65 M
What is ZyVersa Therapeutics TTM EBIT year-on-year change?
Over the past year, ZVSA TTM earnings before interest & taxes has changed by +$3.03 M (+23.93%)